U.S. Markets close in 1 hr 57 mins

SPDR S&P MidCap 400 ETF (MDY)

NYSEArca - Nasdaq Real Time Price. Currency in USD
Add to watchlist
322.86+0.91 (+0.28%)
As of 2:03PM EDT. Market open.
People also watch
Full screen
Previous Close321.95
Bid322.82 x 1300
Ask322.85 x 900
Day's Range322.00 - 323.00
52 Week Range268.25 - 326.88
Avg. Volume1,073,528
Net Assets18B
PE Ratio (TTM)N/A
YTD Return5.04%
Beta (3y)0.97
Expense Ratio (net)0.25%
Inception Date1995-05-04
Trade prices are not sourced from all markets
  • Chartmaster Carter Worth says forget big tech, buy this g...
    CNBC Videos21 hours ago

    Chartmaster Carter Worth says forget big tech, buy this g...

    Carter Worth, Cornerstone Macro, discusses how to trade technology after the sector dipped. The “Fast Money” traders weigh in.

  • ETF.com15 days ago

    Least Popular ETFs Of The Year

    It may be surprising to hear that in a year in which ETFs are shattering all sorts of records with regard to the amount of money they are taking in, the world's largest exchange-traded fund isn't participating in the bonanza. That's right; the SPDR S&P 500 ETF Trust (SPY), the $242 billion behemoth, has actually had net outflows this year to the tune of $4.2 billion.

  • Market Realist20 days ago

    How Are Bioverativ’s Key Drugs Positioned after 2Q17?

    In 2Q17, Bioverativ’s Alprolix generated revenues of ~$89.7 million, which represents ~12% growth YoY (year-over-year) and ~4% growth sequentially.